The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
NEW YORK — The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, particularly in drug discovery and development. Dotmatics, a company ...
As drug costs rise and public trust falls, A.I. may transform the economics of clinical trials—and reshape the future of pharma. Unsplash+ Sixty percent of the total U.S. population takes at least one ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets ...
Insilico Medicine (“Insilico”), a world-leading artificial intelligence (AI)-driven drug discovery company, today announced a ...
Edesa Biotech, Inc. has announced its financial results for the first half of 2025, highlighting a $15 million equity financing aimed at advancing its vitiligo drug candidate, EB06, an anti-CXCL10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback